B CELL-TARGETED THERAPY WITH ANTI-CD20 MONOCLONAL ANTIBODY REDUCED SECONDARY TISSUE DAMAGE AND ENHANCED BEHAVIORAL RECOVERY FOLLOWING EXPERIMENTAL SPINAL CORD INJURY IN MICE

被引：0
|
作者：
Esposito, E. [1 ]
Paterniti, I [1 ]
Cordaro, M. [1 ]
Crupi, R. [1 ]
Siracusa, R. [1 ]
Cuzzocrea, S. [1 ]
机构：
[1] Univ Messina, Dept Biol & Environm Sci, I-98100 Messina, Italy
来源：
SHOCK | 2015年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
INF/IR-5
引用
收藏
页码：8 / 8
页数：1
相关论文
共 43 条
  • [1] B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism
    Ueki, I.
    Abiru, N.
    Kobayashi, M.
    Nakahara, M.
    Ichikawa, T.
    Eguchi, K.
    Nagayama, Y.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 163 (03): : 309 - 317
  • [2] A therapeutic time window for anti-CD11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury
    Ditor, David S.
    Bao, Feng
    Chen, Yuhua
    Dekaban, Gregory A.
    Weaver, Lynne C.
    [J]. JOURNAL OF NEUROSURGERY-SPINE, 2006, 5 (04) : 343 - 352
  • [3] T Cell Delivery of Nanoparticles-Bound Anti-CD20 Monoclonal Antibody: Successful B Cell Depletion in the Spinal Cord during Experimental Autoimmune Encephalomyelitis
    Carnasciali, Alberto
    Amoriello, Roberta
    Bonechi, Elena
    Mazzoni, Alessio
    Ravagli, Costanza
    Doumett, Saer
    Cappiello, Laura
    D'Elios, Mario Milco
    Baldi, Giovanni
    Ballerini, Clara
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2021, 16 (02) : 376 - 389
  • [4] T Cell Delivery of Nanoparticles-Bound Anti-CD20 Monoclonal Antibody: Successful B Cell Depletion in the Spinal Cord during Experimental Autoimmune Encephalomyelitis
    Alberto Carnasciali
    Roberta Amoriello
    Elena Bonechi
    Alessio Mazzoni
    Costanza Ravagli
    Saer Doumett
    Laura Cappiello
    Mario Milco D’Elios
    Giovanni Baldi
    Clara Ballerini
    [J]. Journal of Neuroimmune Pharmacology, 2021, 16 : 376 - 389
  • [5] Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan
    Kensei Tobinai
    [J]. International Journal of Hematology, 2002, 76 : 411 - 419
  • [6] Monoclonal antibody therapy for B-Cell lymphoma: Clinical trials of an anti-CD20 monoclonal antibody for B-cell lymphoma in Japan
    Tobinai, K
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (05) : 411 - 419
  • [7] T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma
    Vincent-Salomon, A
    Mathiot, C
    MacIntyre, E
    Girre, V
    Fourquet, A
    Mercier, C
    Fréneaux, P
    Dumont, J
    Decaudin, D
    [J]. LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 387 - +
  • [8] CD20-negative relapse of cutaneous B-cell lymphoma after anti-CD20 monoclonal antibody therapy
    Massengale, WT
    McBurney, E
    Gurtler, J
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (03) : 441 - 443
  • [9] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    [J]. ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [10] Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab
    Pickartz, T
    Ringel, F
    Wedde, M
    Renz, H
    Klein, A
    von Neuhoff, N
    Dreger, P
    Kreuzer, KA
    Schmidt, CA
    Srock, S
    Schoeler, D
    Schriever, F
    [J]. EXPERIMENTAL HEMATOLOGY, 2001, 29 (12) : 1410 - 1416
12345